Kindeva Drug Delivery
Manufacturing More Tomorrows
About Kindeva Drug Delivery
Kindeva Drug Delivery is a global contract development and manufacturing organization (CDMO) that specializes in drug-device combination products and complex drug programs. Its services span formulation and product development, scale-up, and commercial manufacturing across injectable, inhalation/pulmonary, nasal, transdermal, and microneedle (intradermal) drug delivery. The company was formed in 2020 when 3M's Drug Delivery Systems business was acquired by Altaris Capital Partners and renamed Kindeva.
Industry
Pharmaceutical and medicine manufacturing (contract development and manufacturing organization)
Headquarters
Woodbury, Minnesota, United States
Company size
Approximately 900–1,000 employees
Founded
2020
What we do
Injectable drug deliveryInhalation / pulmonary drug delivery (metered-dose inhalers)Nasal drug deliveryTransdermal drug deliveryMicroneedle / microstructured transdermal (intradermal) systemsFormulation and product developmentScale-up and commercial manufacturingSterile fill-finish (aseptic manufacturing)
Interested in Kindeva Drug Delivery?
Join our talent pool to be considered for future opportunities.